| Literature DB >> 16093349 |
Chrystelle Lamagna1, Paolo Meda, Guillaume Mandicourt, James Brown, Robert J C Gilbert, E Yvonne Jones, Friedemann Kiefer, Pilar Ruga, Beat A Imhof, Michel Aurrand-Lions.
Abstract
The junctional adhesion molecules (JAMs) have been recently described as interendothelial junctional molecules and as integrin ligands. Here we show that JAM-B and JAM-C undergo heterophilic interaction in cell-cell contacts and that JAM-C is recruited and stabilized in junctional complexes by JAM-B. In addition, soluble JAM-B dissociates soluble JAM-C homodimers to form JAM-B/JAM-C heterodimers. This suggests that the affinity of JAM-C monomers to form dimers is higher for JAM-B than for JAM-C. Using antibodies against JAM-C, the formation of JAM-B/JAM-C heterodimers can be abolished. This liberates JAM-C from its vascular binding partner JAM-B and makes it available on the apical side of vessels for interaction with its leukocyte counter-receptor alpha(M)beta2 integrin. We demonstrate that the modulation of JAM-C localization in junctional complexes is a new regulatory mechanism for alpha(M)beta2-dependent adhesion of leukocytes.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16093349 PMCID: PMC1237098 DOI: 10.1091/mbc.e05-04-0310
Source DB: PubMed Journal: Mol Biol Cell ISSN: 1059-1524 Impact factor: 4.138